SIONNA THERAPEUTICS INC (SION) Stock Income Statement
USA - NASDAQ:SION - US8294011080 - Common Stock
39.21 USD
-0.39 (-0.98%)
39.21 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 112.12M | 70.56M | 50.33M | 41.37M | |||
| Research and Development | 86.34M | 57.29M | 40.63M | 34.60M | |||
| Selling, General, and Administrative Expenses | 25.78M | 13.27M | 9.71M | 6.77M | |||
| Operating Income | -112.12M | -70.56M | -50.33M | -41.37M | |||
| Interest Income/Expense | 14.84M | 8.17M | 2.77M | 1.13M | |||
| Other Income/Expense | 1.05M | 698.00K | 301.00K | 0.00 | |||
| Income Before Taxes | -96.24M | -61.69M | -47.26M | -40.24M | |||
| Net Income | -96.24M | -61.69M | -47.26M | -40.24M | |||
| EBITDA | -111.15M | -69.89M | -49.75M | -41.25M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -2.23 | -1.45 | -1.11 | -0.95 | |||
| Statistics | |||||||
All data in USD